Chronic lithium administration ameliorates 2,4,6-trinitrobenzene sulfonic acid-induced colitis in rats; potential role for adenosine triphosphate sensitive potassium channels

Ali Daneshmand, Hamed Mohammadi, Reza Rahimian, Peiman Habibollahi, Gohar Fakhfouri, Saman Shafat Talab, Shahram Ejtemaei Mehr, Ahmad Reza Dehpour

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background and Aim: Inflammatory bowel disease (IBD) is a multi-factorial disease with an unknown etiology characterized by oxidative stress, leukocyte infiltration and a rise in inflammatory cytokines. This study was conducted to investigate lithium in 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced chronic model of experimental IBD, and the contribution of potassium channels as a possible underlying mechanism. Methods: Experimental IBD was induced in rats by a single colonic administration of 10mg of TNBS. Lithium, Glibenclamide (a potassium channel blocker), Lithium+Glibenclamide, Cromakalim or Lithium+Glibenclamide+Cromakalim were given twice daily for 7 successive days. At the end of the experiment, macroscopic and histopathologic scores, colonic malondialdehyde (MDA), tumor necrosis factor-α (TNF-α) level, and myeloperoxidase (MPO) activity as well as plasma lithium level were assessed. Results: Both macroscopic and histological features of colonic injury were markedly ameliorated by lithium. Likewise, the elevated amounts of MPO and MDA were diminished as well as those of TNF-α (P<0.05). Glibenclamide reversed the effect of lithium on these markers, Addition of cromakalim abrogated the effects mediated by glibenclamide and markedly decreased MPO activity, MDA level and TNF-α content (P<0.0.05). Macroscopic and microscopic scores and biochemical markers were significantly decreased in Cromakalim-treated animals. No significant difference was observed between TNBS and Glibenclamide groups. Conclusion: Lithium exerts prominent anti-inflammatory effects on TNBS-induced colitis in rats. Potassium channels contribute to these beneficial properties.

Original languageEnglish (US)
Pages (from-to)1174-1181
Number of pages8
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume26
Issue number7
DOIs
StatePublished - Jul 2011
Externally publishedYes

Fingerprint

Sulfonic Acids
Potassium Channels
Colitis
Lithium
Glyburide
Adenosine Triphosphate
Cromakalim
Malondialdehyde
Inflammatory Bowel Diseases
Peroxidase
Tumor Necrosis Factor-alpha
Potassium Channel Blockers
sym-trinitrobenzene
Oxidative Stress
Leukocytes
Anti-Inflammatory Agents
Theoretical Models
Biomarkers
Cytokines
Wounds and Injuries

Keywords

  • 2, 4, 6-trinitrobenzene sulfonic acid
  • Inflammatory bowel disease
  • Lithium
  • Potassium channel

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Chronic lithium administration ameliorates 2,4,6-trinitrobenzene sulfonic acid-induced colitis in rats; potential role for adenosine triphosphate sensitive potassium channels. / Daneshmand, Ali; Mohammadi, Hamed; Rahimian, Reza; Habibollahi, Peiman; Fakhfouri, Gohar; Talab, Saman Shafat; Mehr, Shahram Ejtemaei; Dehpour, Ahmad Reza.

In: Journal of Gastroenterology and Hepatology (Australia), Vol. 26, No. 7, 07.2011, p. 1174-1181.

Research output: Contribution to journalArticle

Daneshmand, Ali ; Mohammadi, Hamed ; Rahimian, Reza ; Habibollahi, Peiman ; Fakhfouri, Gohar ; Talab, Saman Shafat ; Mehr, Shahram Ejtemaei ; Dehpour, Ahmad Reza. / Chronic lithium administration ameliorates 2,4,6-trinitrobenzene sulfonic acid-induced colitis in rats; potential role for adenosine triphosphate sensitive potassium channels. In: Journal of Gastroenterology and Hepatology (Australia). 2011 ; Vol. 26, No. 7. pp. 1174-1181.
@article{611c9aeade0e4020ab77956811fbfe24,
title = "Chronic lithium administration ameliorates 2,4,6-trinitrobenzene sulfonic acid-induced colitis in rats; potential role for adenosine triphosphate sensitive potassium channels",
abstract = "Background and Aim: Inflammatory bowel disease (IBD) is a multi-factorial disease with an unknown etiology characterized by oxidative stress, leukocyte infiltration and a rise in inflammatory cytokines. This study was conducted to investigate lithium in 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced chronic model of experimental IBD, and the contribution of potassium channels as a possible underlying mechanism. Methods: Experimental IBD was induced in rats by a single colonic administration of 10mg of TNBS. Lithium, Glibenclamide (a potassium channel blocker), Lithium+Glibenclamide, Cromakalim or Lithium+Glibenclamide+Cromakalim were given twice daily for 7 successive days. At the end of the experiment, macroscopic and histopathologic scores, colonic malondialdehyde (MDA), tumor necrosis factor-α (TNF-α) level, and myeloperoxidase (MPO) activity as well as plasma lithium level were assessed. Results: Both macroscopic and histological features of colonic injury were markedly ameliorated by lithium. Likewise, the elevated amounts of MPO and MDA were diminished as well as those of TNF-α (P<0.05). Glibenclamide reversed the effect of lithium on these markers, Addition of cromakalim abrogated the effects mediated by glibenclamide and markedly decreased MPO activity, MDA level and TNF-α content (P<0.0.05). Macroscopic and microscopic scores and biochemical markers were significantly decreased in Cromakalim-treated animals. No significant difference was observed between TNBS and Glibenclamide groups. Conclusion: Lithium exerts prominent anti-inflammatory effects on TNBS-induced colitis in rats. Potassium channels contribute to these beneficial properties.",
keywords = "2, 4, 6-trinitrobenzene sulfonic acid, Inflammatory bowel disease, Lithium, Potassium channel",
author = "Ali Daneshmand and Hamed Mohammadi and Reza Rahimian and Peiman Habibollahi and Gohar Fakhfouri and Talab, {Saman Shafat} and Mehr, {Shahram Ejtemaei} and Dehpour, {Ahmad Reza}",
year = "2011",
month = "7",
doi = "10.1111/j.1440-1746.2011.06719.x",
language = "English (US)",
volume = "26",
pages = "1174--1181",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Chronic lithium administration ameliorates 2,4,6-trinitrobenzene sulfonic acid-induced colitis in rats; potential role for adenosine triphosphate sensitive potassium channels

AU - Daneshmand, Ali

AU - Mohammadi, Hamed

AU - Rahimian, Reza

AU - Habibollahi, Peiman

AU - Fakhfouri, Gohar

AU - Talab, Saman Shafat

AU - Mehr, Shahram Ejtemaei

AU - Dehpour, Ahmad Reza

PY - 2011/7

Y1 - 2011/7

N2 - Background and Aim: Inflammatory bowel disease (IBD) is a multi-factorial disease with an unknown etiology characterized by oxidative stress, leukocyte infiltration and a rise in inflammatory cytokines. This study was conducted to investigate lithium in 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced chronic model of experimental IBD, and the contribution of potassium channels as a possible underlying mechanism. Methods: Experimental IBD was induced in rats by a single colonic administration of 10mg of TNBS. Lithium, Glibenclamide (a potassium channel blocker), Lithium+Glibenclamide, Cromakalim or Lithium+Glibenclamide+Cromakalim were given twice daily for 7 successive days. At the end of the experiment, macroscopic and histopathologic scores, colonic malondialdehyde (MDA), tumor necrosis factor-α (TNF-α) level, and myeloperoxidase (MPO) activity as well as plasma lithium level were assessed. Results: Both macroscopic and histological features of colonic injury were markedly ameliorated by lithium. Likewise, the elevated amounts of MPO and MDA were diminished as well as those of TNF-α (P<0.05). Glibenclamide reversed the effect of lithium on these markers, Addition of cromakalim abrogated the effects mediated by glibenclamide and markedly decreased MPO activity, MDA level and TNF-α content (P<0.0.05). Macroscopic and microscopic scores and biochemical markers were significantly decreased in Cromakalim-treated animals. No significant difference was observed between TNBS and Glibenclamide groups. Conclusion: Lithium exerts prominent anti-inflammatory effects on TNBS-induced colitis in rats. Potassium channels contribute to these beneficial properties.

AB - Background and Aim: Inflammatory bowel disease (IBD) is a multi-factorial disease with an unknown etiology characterized by oxidative stress, leukocyte infiltration and a rise in inflammatory cytokines. This study was conducted to investigate lithium in 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced chronic model of experimental IBD, and the contribution of potassium channels as a possible underlying mechanism. Methods: Experimental IBD was induced in rats by a single colonic administration of 10mg of TNBS. Lithium, Glibenclamide (a potassium channel blocker), Lithium+Glibenclamide, Cromakalim or Lithium+Glibenclamide+Cromakalim were given twice daily for 7 successive days. At the end of the experiment, macroscopic and histopathologic scores, colonic malondialdehyde (MDA), tumor necrosis factor-α (TNF-α) level, and myeloperoxidase (MPO) activity as well as plasma lithium level were assessed. Results: Both macroscopic and histological features of colonic injury were markedly ameliorated by lithium. Likewise, the elevated amounts of MPO and MDA were diminished as well as those of TNF-α (P<0.05). Glibenclamide reversed the effect of lithium on these markers, Addition of cromakalim abrogated the effects mediated by glibenclamide and markedly decreased MPO activity, MDA level and TNF-α content (P<0.0.05). Macroscopic and microscopic scores and biochemical markers were significantly decreased in Cromakalim-treated animals. No significant difference was observed between TNBS and Glibenclamide groups. Conclusion: Lithium exerts prominent anti-inflammatory effects on TNBS-induced colitis in rats. Potassium channels contribute to these beneficial properties.

KW - 2, 4, 6-trinitrobenzene sulfonic acid

KW - Inflammatory bowel disease

KW - Lithium

KW - Potassium channel

UR - http://www.scopus.com/inward/record.url?scp=79958783190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958783190&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1746.2011.06719.x

DO - 10.1111/j.1440-1746.2011.06719.x

M3 - Article

C2 - 21401719

AN - SCOPUS:79958783190

VL - 26

SP - 1174

EP - 1181

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 7

ER -